BioMaxima Statistics
Total Valuation
BioMaxima has a market cap or net worth of PLN 58.28 million. The enterprise value is 68.31 million.
Market Cap | 58.28M |
Enterprise Value | 68.31M |
Important Dates
The last earnings date was Tuesday, June 3, 2025.
Earnings Date | Jun 3, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
BioMaxima has 4.19 million shares outstanding. The number of shares has decreased by -1.53% in one year.
Current Share Class | 4.19M |
Shares Outstanding | 4.19M |
Shares Change (YoY) | -1.53% |
Shares Change (QoQ) | +0.33% |
Owned by Insiders (%) | 22.38% |
Owned by Institutions (%) | n/a |
Float | 2.69M |
Valuation Ratios
The trailing PE ratio is 66.85.
PE Ratio | 66.85 |
Forward PE | n/a |
PS Ratio | 1.03 |
PB Ratio | 1.22 |
P/TBV Ratio | 1.23 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.00, with an EV/FCF ratio of -22.94.
EV / Earnings | 78.15 |
EV / Sales | 1.21 |
EV / EBITDA | 13.00 |
EV / EBIT | 36.53 |
EV / FCF | -22.94 |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.22.
Current Ratio | 1.44 |
Quick Ratio | 0.74 |
Debt / Equity | 0.22 |
Debt / EBITDA | 2.02 |
Debt / FCF | -3.56 |
Interest Coverage | 1.91 |
Financial Efficiency
Return on equity (ROE) is 1.84% and return on invested capital (ROIC) is 1.98%.
Return on Equity (ROE) | 1.84% |
Return on Assets (ROA) | 1.52% |
Return on Invested Capital (ROIC) | 1.98% |
Return on Capital Employed (ROCE) | 3.16% |
Revenue Per Employee | 449,556 |
Profits Per Employee | 6,937 |
Employee Count | 126 |
Asset Turnover | 0.74 |
Inventory Turnover | 2.23 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.63% in the last 52 weeks. The beta is 0.46, so BioMaxima's price volatility has been lower than the market average.
Beta (5Y) | 0.46 |
52-Week Price Change | -14.63% |
50-Day Moving Average | 13.21 |
200-Day Moving Average | 13.78 |
Relative Strength Index (RSI) | 50.49 |
Average Volume (20 Days) | 16,022 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioMaxima had revenue of PLN 56.64 million and earned 874,000 in profits. Earnings per share was 0.21.
Revenue | 56.64M |
Gross Profit | 26.74M |
Operating Income | 1.87M |
Pretax Income | 736,000 |
Net Income | 874,000 |
EBITDA | 4.97M |
EBIT | 1.87M |
Earnings Per Share (EPS) | 0.21 |
Balance Sheet
The company has 577,000 in cash and 10.60 million in debt, giving a net cash position of -10.02 million or -2.39 per share.
Cash & Cash Equivalents | 577,000 |
Total Debt | 10.60M |
Net Cash | -10.02M |
Net Cash Per Share | -2.39 |
Equity (Book Value) | 47.82M |
Book Value Per Share | 11.37 |
Working Capital | 8.91M |
Cash Flow
In the last 12 months, operating cash flow was -1.04 million and capital expenditures -1.94 million, giving a free cash flow of -2.98 million.
Operating Cash Flow | -1.04M |
Capital Expenditures | -1.94M |
Free Cash Flow | -2.98M |
FCF Per Share | -0.71 |
Margins
Gross margin is 47.20%, with operating and profit margins of 3.30% and 1.54%.
Gross Margin | 47.20% |
Operating Margin | 3.30% |
Pretax Margin | 1.30% |
Profit Margin | 1.54% |
EBITDA Margin | 8.78% |
EBIT Margin | 3.30% |
FCF Margin | n/a |
Dividends & Yields
BioMaxima does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 1.53% |
Shareholder Yield | n/a |
Earnings Yield | 1.50% |
FCF Yield | -5.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |